Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 6Breast 5Lymphoid 4Genitourinary 3Gastrointestinal 3Thoracic 1Sarcoma 1Plasma cell 1Dermatologic 1

Conditions

Sarcoma 219Osteosarcoma 91Bone Neoplasms 76Gastrointestinal Stromal Tumors 67Neoplasms 55Melanoma 41Sarcoma, Ewing 32Breast Neoplasms 31Lymphoma 30Dendritic Cell Sarcoma, Interdigitating 27Leukemia 25Stomach Neoplasms 23Sarcoma, Kaposi 23Prostatic Neoplasms 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Brain Neoplasms 22Uterine Cervical Neoplasms 20Pancreatic Neoplasms 20Ovarian Neoplasms 20Neuroblastoma 20Esophageal Neoplasms 20Central Nervous System Neoplasms 20Lymphoma, Non-Hodgkin 18Lung Neoplasms 18Glioblastoma 18Desmoid Tumors 18Rhabdomyosarcoma 17Colorectal Neoplasms 17Colonic Neoplasms 17Multiple Myeloma 16

Interventions

glucarpidase 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Drug-Related Side Effects and Adverse Reactions × Sarcoma × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡